Can a smartphone app help young people with psychosis cut back on cannabis?
NCT ID NCT05310981
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested a mobile app called iCanChange in 100 young adults (ages 18-35) with psychosis and cannabis use disorder. The app uses motivational interviewing and cognitive behavioral therapy techniques through short interactive modules. The main goal was to see if the app is acceptable and feasible to use, not whether it actually reduces cannabis use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
iCanChange mobile app (behavioral intervention using motivational interviewing and cognitive behavioral therapy)
What this could lead to
If successful, this could point toward a practical, app-based tool to help young people with psychosis cut down on cannabis use.
What could go wrong
This is a small pilot study (100 participants) focused on feasibility, not effectiveness. The app may not lead to lasting changes in cannabis use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinic Connec-T - Institut universitaire en santé mentale de Montréal
Montreal, Quebec, H1N3M5, Canada
-
Clinic Notre-Dame des Victoires - Centre de Recherche CERVO
Québec, Quebec, G1J2G3, Canada
-
Clinique JAP, Centre hospitalier de l'Université de Montréal
Montreal, Quebec, H2X 3E4, Canada
-
Foothills Medical Centre Early Psychosis Intervention Program
Calgary, Alberta, T2N2T9, Canada
-
Nova Scotia Early Psychosis Program
Halifax, Nova Scotia, B3H2E2, Canada